ZnS Cu-doped quantum dots

The paper presents a survey of literature on the structure and optical properties of ZnS and copper ion-doped ZnS quantum dots. The effect of other metal dopants on the spectral properties of ZnS:Cu quantum dots was also considered. The influence of such parameters as dopant concentration, temperature of the synthesis and compounds which form or modify the additional layer on dots on spectral properties of the quantum dots was described. Examples of application of ZnS:Cu quantum dots are also given

Adipose derived stromal cells in cardiovascular regenerative medicine

Cardiovascular diseases are the leading cause of death globally. Myocardial Infarction occurs due to the occlusion of one of the branches of the coronary artery system. Once the coronary artery occludes, the downstream myocardium is deprived of oxygen and nutrition, which lead to myocardial ischemia. Prolonged ischemia results in the death of cardiomyocytes and surrounding vasculature. Subsequently, the death signals from apoptotic and necrotic cells activate rapid inflammatory reaction, which dominates the early post-MI microenvironment. A promising approach for induction of cardiac repair is cell-based therapy. Recent clinical trials with intramyocardial injection of freshly isolated ADSC demonstrated improvement of cardiac parameters, increased revascularization and finally the quality of life. In this thesis we acquired better understanding of use of Adipose-tissue Derived Stem/Stromal Cells in post-myocardial infarction therapy. We have shown that in contrast to the previous paradigm, therapeutic cells of mesenchymal origin such as ADSC gain higher regenerative potential under hypoxic and pro-inflammatory conditions, which render them the most promising cells for cardiac therapy. We have identified that not only ADSC but their secreted factors in the conditioned medium or deposited extracellular matrix enhance cardiomyocyte proliferation, organization and maturation as well as lead to increased vascular network formation. The use of ADSC or ADSC-secretors could help to overcome the limitation of cardiac cell therapy as well as offer of-the-shelf product for immediate application. We propose that use of ADSC or ADSC-derived conditioned medium or extracellular matrix components based therapy is feasible and clinically relevant option for treatment of post-MI complications

The study of phenylboronic acid optical properties towards creation of a glucose sensor

The article presents influence of pH and glucose concentration on phenylboronic acid (PBA) fluorescence studied by steady-state and time-resolved measurements. Fluorescence of PBA decreases with growing pH. These changes reflected acid-base equilibrium of PBA and allowed to estimate value of pKd as 9.2, which is comparable with literature data. Fluorescence intensity of phenylboronic acid is quenched in presence of glucose. The effect of quenching is more pronounced with increasing pH. At pH 7 quenching can be described by Stern-Volmer equation, at pH 8 and 9 by modified one. The obtained quenching constants are growing with pH increase. The quenching of phenylboronic acid fluorescence by glucose is a static one, which is confirmed by time-resolved measurements. Two lifetimes were found for fluorescence decay of phenylboronic acid. The lifetimes are practically independent on pH and glucose concentration and also fraction of both lifetimes are nearly the same. The obtained Stern-Volmer constants can be interpreted as apparent equilibrium constants of ester formation between acid and glucose

Human adipose tissue-derived stromal cells act as functional pericytes in mice and suppress high-glucose-induced proinflammatory activation of bovine retinal endothelial cells

The immunomodulatory capacity of adipose tissue-derived stromal cells (ASCs) is relevant for next-generation cell therapies that aim to reverse tissue dysfunction such as that caused by diabetes. Pericyte dropout from retinal capillaries underlies diabetic retinopathy and the subsequent aberrant angiogenesis. We investigated the pericytic function of ASCs after intravitreal injection of ASCs in mice with retinopathy of prematurity as a model for clinical diabetic retinopathy. In addition, ASCs influence their environment by paracrine signalling. For this, we assessed the immunomodulatory capacity of conditioned medium from cultured ASCs (ASC-Cme) on high glucose (HG)-stimulated bovine retinal endothelial cells (BRECs). ASCs augmented and stabilised retinal angiogenesis and co-localised with capillaries at a pericyte-specific position. This indicates that cultured ASCs exert juxtacrine signalling in retinal microvessels. ASC-Cme alleviated HG-induced oxidative stress and its subsequent upregulation of downstream targets in an NF-kappa B dependent fashion in cultured BRECs. Functionally, monocyte adhesion to the monolayers of activated BRECs was also decreased by treatment with ASC-Cme and correlated with a decline in expression of adhesion-related genes such as SELE, ICAM1 and VCAM1. The ability of ASC-Cme to immunomodulate HG-challenged BRECs is related to the length of time for which ASCs were preconditioned in HG medium. Conditioned medium from ASCs that had been chronically exposed to HG medium was able to normalise the HG-challenged BRECs to normal glucose levels. In contrast, conditioned medium from ASCs that had been exposed to HG medium for a shorter time did not have this effect. Our results show that the manner of HG preconditioning of ASCs dictates their immunoregulatory properties and thus the potential outcome of treatment of diabetic retinopathy

Mesenchymal Stem Cells: Promising for Myocardial Regeneration?

The pandemic of cardiovascular disease is continuously expanding as the result of changing life styles and diets throughout the Old and New World. Immediate intervention therapy saves the lives of many patients after acute myocardial infarction (MI). However, for many this comes at the price of adverse cardiac remodeling and heart failure. Currently, no conventional therapy can prevent the negative aftermath of MI and alternative treatments are warranted. Therefore, cardiac stem cell therapy has been put forward over the past decade, albeit with modest successes. Mesenchymal Stem Cells (MSC) are promising because these are genuine cellular factories of a host of secreted therapeutic factors. MSC are obtained from bone marrow or adipose tissue (ADSC). However, the heart itself also contains mesenchymal-like stem cells, though more difficult to acquire than ADSC. Interestingly, mesenchymal cells such as fibroblasts can be directly or indirectly reprogrammed to all myocardial cell types that require replacement after MI. To date, the paracrine and juxtacrine mechanisms of ADSC and other MSC on vessel formation are best understood. The preconditioning of, otherwise naive, stem cells is gaining more interest: previously presumed deleterious stimuli such as hypoxia and inflammation, i.e. causes of myocardial damage, have the opposite effect on mesenchymal stem cells. MSC gain a higher therapeutic capacity under hypoxia and inflammatory conditions. In this review, mesenchymal stem cells and their working mechanisms are put into the perspective of clinical cardiac stem cell therapy

Mesenchymal Stem Cells:Promising for Myocardial Regeneration?

The pandemic of cardiovascular disease is continuously expanding as the result of changing life styles and diets throughout the Old and New World. Immediate intervention therapy saves the lives of many patients after acute myocardial infarction (MI). However, for many this comes at the price of adverse cardiac remodeling and heart failure. Currently, no conventional therapy can prevent the negative aftermath of MI and alternative treatments are warranted. Therefore, cardiac stem cell therapy has been put forward over the past decade, albeit with modest successes. Mesenchymal Stem Cells (MSC) are promising because these are genuine cellular factories of a host of secreted therapeutic factors. MSC are obtained from bone marrow or adipose tissue (ADSC). However, the heart itself also contains mesenchymal-like stem cells, though more difficult to acquire than ADSC. Interestingly, mesenchymal cells such as fibroblasts can be directly or indirectly reprogrammed to all myocardial cell types that require replacement after MI. To date, the paracrine and juxtacrine mechanisms of ADSC and other MSC on vessel formation are best understood. The preconditioning of, otherwise naive, stem cells is gaining more interest: previously presumed deleterious stimuli such as hypoxia and inflammation, i.e. causes of myocardial damage, have the opposite effect on mesenchymal stem cells. MSC gain a higher therapeutic capacity under hypoxia and inflammatory conditions. In this review, mesenchymal stem cells and their working mechanisms are put into the perspective of clinical cardiac stem cell therapy

Extracellular matrix components of adipose derived stromal cells promote alignment, organization, and maturation of cardiomyocytes in vitro

Adipose derived stromal cells (ADSC) are relevant therapeutic agents to treat myocardial infarction (MI) in clinical trials. Soluble factors secreted by ADSC, such as growth factors and cytokines, suppress inflammation and apoptosis while promoting angiogenesis and the proliferation of cardiomyocytes (CM). Moreover, ADSC synthesize extracellular matrix (ECM) components into the intercellular space which might contribute to their therapeutic capacity. Thus, ADSC might directly modulate the post-MI microenvironment through a combination of paracrine and juxtacrine signaling. In this study, the juxtacrine role of ADSC and ADSC-derived ECM on the organization and maturation of CM was investiagated. Human ADSC synthesized and deposited a heterogenous and complex mixture of ECM components such as collagen I, III, IV, fibronectin, elastin as well as the matricellular protein periostin. Cocultures of rodent CM with human ADSC or with human ADSC-derived ECM components enhanced the cardiomyocyte alignment, their intercellular connections and the maturation of their sarcomeres, while the proliferation rate of the CM was increased and their level of hypertrophy reduced. The use of human ADSC-derived ECM could serve both to augment in vitro tissue-engineered myocardial constructs and to improve myocardial remodeling after infarction. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1840-1848, 2015